Diabetes Assays are tests to first diagnose diabetes and assess the risk of diabetes, such as pre-diabetes, through analysis of blood.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Diabetes Assays under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Diabetes Assays and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to :
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Diabetes Assays under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 1Drop Diagnostics
- Abcodia Ltd
- Abionic SA
- Adaptive Biotechnologies Corp
- Adipomics Inc
- Aditxt Inc
- Advanced Genetic Diagnostics Pty Ltd
- Alfa Wassermann Inc
- AmideBio, LLC
- Aura Biotechnologies Pvt Ltd
- Beckman Coulter Inc
- Biocrates Life Sciences AG
- BioDesign Institute at Arizona State University
- Biogenes Technologies Sdn Bhd
- Biomorph Technologies LLC
- CellCarta Precision Medicine Inc
- Confer Health Inc
- Drexel University
- Dx&Vx
- Electronic BioSciences Inc.
- Enable Biosciences Inc
- FibroStatin SL
- G Medical Innovations Holdings Ltd
- GATC DB Care Corp
- Gelteq Ltd
- Genesis Detection Systems, Inc.
- Guangzhou Wondfo Biotech Co Ltd
- Helmholtz Centre for Infection Research
- Hemex Health Inc
- Human Cell Design SAS
- Interpace Biosciences Inc
- IntraMed Diagnostics, LLC
- Janssen Diagnostics LLC
- Johns Hopkins University
- L2 Diagnostics LLC
- Matter Diagnostics
- MediSure Canada Inc
- Mellitus LLC
- MultiOmic Health Ltd
- Numares AG
- Peri Rx Inc
- Phaim Pharma Ltd
- Phase Scientific International Ltd
- PortaScience Inc
- Precision Diabetes LLC
- Protagen AG
- QSTAG Co Ltd
- Queen Mary University of London
- QuickCheck Health Inc
- Sebia
- Sera Prognostics Inc
- Singulex Inc
- SomaLogic Inc
- SpinChip Diagnostics AS
- Stanford University
- Sugentech Inc
- Tetz Laboratories
- The Forsyth Institute
- University of Canterbury
- University of Colorado
- University of Florida
- University of Newcastle
- University of Oxford
- University of South Florida
- University of Strathclyde
- Vactech Oy
- Vital Diagnostics, Inc. (Inactive)
- Wave 80 Biosciences Inc
- Xhale Inc
- Yaathum Biotech Pvt Ltd
- Yale University

